Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Sees Significant Drop in Short Interest

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the recipient of a large decline in short interest in the month of April. As of April 15th, there was short interest totaling 934,995 shares, a decline of 22.0% from the March 31st total of 1,198,641 shares. Approximately 1.5% of the company’s shares are sold short. Based on an average daily trading volume, of 448,619 shares, the short-interest ratio is presently 2.1 days.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several large investors have recently made changes to their positions in BIOX. Jones Financial Companies Lllp grew its stake in shares of Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after buying an additional 5,339 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after buying an additional 3,735 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of Bioceres Crop Solutions in the 3rd quarter valued at approximately $40,000. Invesco Ltd. bought a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at approximately $45,000. Finally, PDT Partners LLC grew its stake in shares of Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after buying an additional 10,449 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on BIOX. Wall Street Zen downgraded Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. Canaccord Genuity Group cut their price objective on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a report on Friday, January 2nd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Bioceres Crop Solutions currently has a consensus rating of “Hold” and a consensus price target of $4.00.

Bioceres Crop Solutions Stock Up 0.2%

Shares of BIOX traded up $0.00 during trading hours on Friday, reaching $0.47. The company’s stock had a trading volume of 104,649 shares, compared to its average volume of 793,199. The firm has a market cap of $29.60 million, a price-to-earnings ratio of -0.13 and a beta of 0.53. Bioceres Crop Solutions has a 1-year low of $0.35 and a 1-year high of $5.18. The company has a quick ratio of 0.69, a current ratio of 0.90 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average of $0.52 and a two-hundred day moving average of $1.09.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Friday, March 13th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). The business had revenue of $73.67 million during the quarter, compared to analyst estimates of $104.55 million. Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%. As a group, research analysts predict that Bioceres Crop Solutions will post -0.16 EPS for the current fiscal year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.